DNAnexus and Discovery Life Sciences to Streamline Precision Health Data Analysis | Discovery Life Sciences Announces New CEO | Discovery Life Sciences Announces Major Strategic Expansions: New State-of-the-Art Facilities, Advanced Technologies, and Global Brand Enhancements | Discovery Life Sciences expands high-throughput proteomics services |

Mass Spectrometry
(LC-MS/MS)-Based
Proteomics

Expert tailored untargeted and targeted mass spectrometry-based proteomics services

Mass spectrometry-based proteomics is a reliable technology for the identification and quantitative assessment of proteins with exquisite accuracy and sensitivity.

Discovery’s Proteome Center has adopted the latest technologies and offers a wide range of workflow options from automated high-throughput pipelines to customized solutions.

Discovery’s Proteome Center Mass Spectrometry Services

Untargeted and targeted proteomic studies
Compatible with a broad range of model organisms and sample types including cells, tissue, biofluids, FFPE, etc.
Ideal for target and biomarker discovery and development
Move beyond expression levels with detection of variants and post translational modifications (PTMs)
Flexible, diverse, and robust workflows
Large scale biomarker screening
Phenotypic screening
Integrated with genomics, molecular pathology, cell biology and clinical flow cytometry services

Technology Platforms

SCIEX ZenoTOF 7600 Mass Spectrometer

EVOSEP ONE:
EV-1000

Seer Proteograph™

Contact Us